ALOMIE MCCALLUM: Open Payments
NPI 1588250575 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 42 payments from 9 companies in 2025. Trend: 2023 $4,272 · 2024 $1,770 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $374 |
| AstraZeneca Pharmaceuticals LP | 10 | $302 |
| Novo Nordisk Inc | 4 | $80 |
| GlaxoSmithKline, LLC. | 3 | $76 |
| Lilly USA, LLC | 3 | $65 |
| COLOPLAST CORP | 1 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Dexcom, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $20 |
Products named: UBRELVY, FARXIGA, BREZTRI, QULIPTA, TRELEGY ELLIPTA, MOUNJARO, Ozempic, Titan.
Industry payments across NY — which companies pay providers there.
